Refreshing results…
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML
Download from rupress.orgClonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Download from www.nature.comDevelopment and validation of a comprehensive genomic diagnostic tool for myeloid malignancies
Download from www.bloodjournal.orgMissing publications? Search for publications with a matching author name.